Revance Therapeutics Inc (RVNC)

[floblu14]

FWIW - Excerpts:

Brokerage Cowen says the U.S. FDA's call to defer its decision on RVNC's experimental frown line treatment was anticipated due to COVID-19-related travel restrictions

** Cowen says a survey of clinicians indicates that co's treatment is differentiated and "poised to disrupt" the market for products to treat forehead wrinkles, such as AbbVie's Botox

** FDA did not indicate there were any other review issues beyond on-site inspection - RVNC

** Cowen, which rates the stock "outperform", expects the delay to be "modest"; Says facility inspection seems to be the only outstanding issue which could be resolved shortly.

Morgan Stanley